Back
Cartesian Therapeutics Vs. Target Industry Stock Comparison
Sell
26
RNAC
Cartesian Therapeutics
Last Price:
16.95
Seasonality Move:
13.13%
Sell
25
TGT
Target
Last Price:
121.23
Seasonality Move:
4.08%
Sell
26
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy, Sell or Hold?
- The current Cartesian Therapeutics [RNAC] share price is $16.94. The Score for RNAC is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- RNAC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Target (TGT)
is a Sell
Is Target a Buy, Sell or Hold?
- The current Target [TGT] share price is $121.72. The Score for TGT is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- TGT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RNAC Stock Price Chart
What is Cartesian Therapeutics's stock price today?
-
The Cartesian Therapeutics share price today is $16.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing selling pressure, which indicates risk of future bearish movement.
RNAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.75 | Sell |
| Relative Strength Index (14 RSI): | 39.42 | Sell |
| Chaikin Money Flow: | -99129 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.09 - 22.05) | Sell |
| Bollinger Bands (100): | (14.31 - 20.45) | Sell |
TGT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.84 | Sell |
| Relative Strength Index (14 RSI): | 23.97 | Sell |
| Chaikin Money Flow: | -42314401 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (143.94 - 157.22) | Sell |
| Bollinger Bands (100): | (143.14 - 156.64) | Sell |
RNAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.66 | Sell |
| 20-day SMA: | 19.51 | Sell |
| 50-day SMA: | 19.31 | Sell |
| 200-day SMA: | 20 | Sell |
| 8-day EMA: | 17.92 | Sell |
| 20-day EMA: | 18.95 | Sell |
| 50-day EMA: | 19.03 | Sell |
| 200-day EMA: | 21.01 | Sell |
TGT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 150.48 | Sell |
| 20-day SMA: | 150.04 | Sell |
| 50-day SMA: | 152.15 | Sell |
| 200-day SMA: | 153.96 | Sell |
| 8-day EMA: | 146.85 | Sell |
| 20-day EMA: | 149.85 | Sell |
| 50-day EMA: | 150.95 | Sell |
| 200-day EMA: | 149.91 | Sell |
Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.
Target Earnings Growth & TGT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.81 per share, and an increase next year of $0.95 per share.
Cartesian Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Target Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||